Please assess the completion status of the following clinical trial:

Trial Title: Emdogain and Straumann Bone Ceramic in Infrabony Defects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and females must be at least 18 years and not more than 75 years of age~* The patient will have to be able to understand and sign the informed consent prior to starting the study.~* The patient also will have to have the ability and the willingness to comply with all study requirements.~* The patients will be in good general health without any systemic diseases.~* The teeth included in the study will be mandibular molars, maxillary and mandibular premolars, and canines.~* The patients will have to have at least one defect with pocket depth ≥ 5 mm.~* Intra-bony defects will have to have 1 or 2-wall morphology (at least 2/3 of the defect).~* Depth of the intrabony component of at least 3 mm~* The selected sites will have to have vertical intra-bony component ≥ 3 mm and an angle ≥ 30 degrees as assessed from standardized intra-oral radiographs.~* Oral hygiene parameters: Plaque Index (PI) ≤ 20 % and bleeding on probing (BoP) ≤ 20%~Exclusion Criteria:~* Heavy smokers: more than 20 cigarettes per day~* Mucosal diseases such as erosive lichen planus~* History of local radiation therapy~* Presence of oral lesions (such as ulceration, malignancy)~* Teeth with untreated endodontic or cardiologic problems~* Physical handicap that will interfere with patient's ability to exercise good oral hygiene on a regular basis.~* Patients presenting antibiotic treatment within the 3 months preceding the surgical procedure.~* Patients using anti-inflammatory drugs on a regular basis.~* Intra-bony defects with a 3-wall morphology.~* Intra-bony defects with furcation involvement.~* Incisors and maxillary molars, will be excluded.~* Alcoholism or chronically drug abuse causing systemic compromize~* Medical conditions requiring prolonged use of steroids~* Current pregnancy at the time of recruitment and/or breastfeeding women.~* Conditions or circumstances, in the opinion of the investigator, which could represent a general contra-indication for surgical procedure or would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance, or unreliability.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Emdogain PLUS (Type: ACTIVE_COMPARATOR): Straumann Emdogain in combination with Straumann BoneCeramic
- Autogenous bone (Type: ACTIVE_COMPARATOR): Autogenous bone from the patient

Based on this trial design, predict the completion outcome and termination type (if applicable).